BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang P, Wang Q, Liu A, Zhu J, Feng J. ALKBH5 Holds Prognostic Values and Inhibits the Metastasis of Colon Cancer. Pathol Oncol Res 2020;26:1615-23. [PMID: 31506804 DOI: 10.1007/s12253-019-00737-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Shen D, Wang B, Gao Y, Zhao L, Bi Y, Zhang J, Wang N, Kang H, Pang J, Liu Y, Pang L, Chen Z, Zheng Y, Liu H. Detailed resume of RNA m6A demethylases. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.01.003] [Reference Citation Analysis]
2 Selberg S, Seli N, Kankuri E, Karelson M. Rational Design of Novel Anticancer Small-Molecule RNA m6A Demethylase ALKBH5 Inhibitors. ACS Omega 2021;6:13310-20. [PMID: 34056479 DOI: 10.1021/acsomega.1c01289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Tian S, Lai J, Yu T, Li Q, Chen Q. Regulation of Gene Expression Associated With the N6-Methyladenosine (m6A) Enzyme System and Its Significance in Cancer. Front Oncol 2020;10:623634. [PMID: 33552994 DOI: 10.3389/fonc.2020.623634] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
4 Wang J, Wang J, Gu Q, Ma Y, Yang Y, Zhu J, Zhang Q. The biological function of m6A demethylase ALKBH5 and its role in human disease. Cancer Cell Int 2020;20:347. [PMID: 32742194 DOI: 10.1186/s12935-020-01450-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
5 Perry GS, Das M, Woon ECY. Inhibition of AlkB Nucleic Acid Demethylases: Promising New Epigenetic Targets. J Med Chem 2021;64:16974-7003. [PMID: 34792334 DOI: 10.1021/acs.jmedchem.1c01694] [Reference Citation Analysis]
6 Luo Q, Gao Y, Zhang L, Rao J, Guo Y, Huang Z, Li J. Decreased ALKBH5, FTO, and YTHDF2 in Peripheral Blood Are as Risk Factors for Rheumatoid Arthritis. Biomed Res Int 2020;2020:5735279. [PMID: 32884942 DOI: 10.1155/2020/5735279] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
7 Liu C, Yang Z, Li R, Wu Y, Chi M, Gao S, Sun X, Meng X, Wang B. Potential roles of N6-methyladenosine (m6A) in immune cells. J Transl Med 2021;19:251. [PMID: 34103054 DOI: 10.1186/s12967-021-02918-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li K, Luo H, Luo H, Zhu X. Clinical and prognostic pan-cancer analysis of m6A RNA methylation regulators in four types of endocrine system tumors. Aging (Albany NY) 2020;12:23931-44. [PMID: 33237039 DOI: 10.18632/aging.104064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
9 Mu L, Shao Y, Wei L, Chen F, Zhang J. RNA N6-Methyladenosine Regulators Contribute to Tumor Immune Microenvironment and Have Clinical Prognostic Impact in Breast Cancer. Front Genet 2022;12:650499. [DOI: 10.3389/fgene.2021.650499] [Reference Citation Analysis]
10 Hao L, Yin J, Yang H, Li C, Zhu L, Liu L, Zhong J. ALKBH5-mediated m6A demethylation of FOXM1 mRNA promotes progression of uveal melanoma. Aging (Albany NY) 2021;13:4045-62. [PMID: 33428593 DOI: 10.18632/aging.202371] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhang H, Zhao L, Li S, Wang J, Feng C, Li T, Du X. N6-Methylandenosine-Related lncRNAs in Tumor Microenvironment Are Potential Prognostic Biomarkers in Colon Cancer. Front Oncol 2021;11:697949. [PMID: 34178697 DOI: 10.3389/fonc.2021.697949] [Reference Citation Analysis]
12 Liu JY, Li B, Xu EP, Zhong YS. Research development and potential therapeutic value of m6A modification in occurrence and progression of colorectal tumors. Shijie Huaren Xiaohua Zazhi 2021; 29(23): 1373-1381 [DOI: 10.11569/wcjd.v29.i23.1373] [Reference Citation Analysis]
13 Ma L, Lin Y, Sun SW, Xu J, Yu T, Chen WL, Zhang LH, Guo YC, Wang YW, Chen T, Wei JF, Zhu LJ. KIAA1429 is a potential prognostic marker in colorectal cancer by promoting the proliferation via downregulating WEE1 expression in an m6A-independent manner. Oncogene 2021. [PMID: 34819634 DOI: 10.1038/s41388-021-02066-z] [Reference Citation Analysis]
14 Xiang M, Liu W, Tian W, You A, Deng D. RNA N-6-methyladenosine enzymes and resistance of cancer cells to chemotherapy and radiotherapy. Epigenomics 2020;12:801-9. [PMID: 32515221 DOI: 10.2217/epi-2019-0358] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
15 Liu C, Yang S, Zhang Y, Wang C, Du D, Wang X, Liu T, Liang G. Emerging Roles of N6-Methyladenosine Demethylases and Its Interaction with Environmental Toxicants in Digestive System Cancers. Cancer Manag Res 2021;13:7101-14. [PMID: 34526822 DOI: 10.2147/CMAR.S328188] [Reference Citation Analysis]
16 Qu J, Yan H, Hou Y, Cao W, Liu Y, Zhang E, He J, Cai Z. RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential. J Hematol Oncol 2022;15. [DOI: 10.1186/s13045-022-01224-4] [Reference Citation Analysis]
17 Jin D, Guo J, Wu Y, Yang L, Wang X, Du J, Dai J, Chen W, Gong K, Miao S, Li X, Sun H. m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC. Mol Cancer 2020;19:40. [PMID: 32106857 DOI: 10.1186/s12943-020-01161-1] [Cited by in Crossref: 52] [Cited by in F6Publishing: 61] [Article Influence: 26.0] [Reference Citation Analysis]
18 Kowalski-Chauvel A, Lacore MG, Arnauduc F, Delmas C, Toulas C, Cohen-Jonathan-Moyal E, Seva C. The m6A RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells. Cancers (Basel) 2020;13:E40. [PMID: 33375621 DOI: 10.3390/cancers13010040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
19 Chen DH, Zhang JG, Wu CX, Li Q. Non-Coding RNA m6A Modification in Cancer: Mechanisms and Therapeutic Targets. Front Cell Dev Biol 2021;9:778582. [PMID: 35004679 DOI: 10.3389/fcell.2021.778582] [Reference Citation Analysis]
20 Bayoumi M, Munir M. Structural Insights Into m6A-Erasers: A Step Toward Understanding Molecule Specificity and Potential Antiviral Targeting. Front Cell Dev Biol 2020;8:587108. [PMID: 33511112 DOI: 10.3389/fcell.2020.587108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Guo J, Zheng J, Zhang H, Tong J. RNA m6A methylation regulators in ovarian cancer. Cancer Cell Int 2021;21:609. [PMID: 34794452 DOI: 10.1186/s12935-021-02318-8] [Reference Citation Analysis]
22 Zhao Z, Wan J, Guo M, Wang Y, Yang Z, Zhou F, Li Z, Ming L. Expression and prognostic significance of m6A-related genes in TP53-mutant non-small-cell lung cancer. J Clin Lab Anal 2021;:e24118. [PMID: 34812534 DOI: 10.1002/jcla.24118] [Reference Citation Analysis]
23 Yan G, An Y, Xu B, Wang N, Sun X, Sun M. Potential Impact of ALKBH5 and YTHDF1 on Tumor Immunity in Colon Adenocarcinoma. Front Oncol 2021;11:670490. [PMID: 34079761 DOI: 10.3389/fonc.2021.670490] [Reference Citation Analysis]